OUR EXPERIENCE IN THE PAST 4 YEARS SUPPORTING OUR CUSTOMER
At every stage of the drug development process, ReachCatalyst deploys the expertise you need to design, plan and execute your clinical trials with skill, precision and unwavering focus on quality delivering .
Our Service & Programs
RaachCatalyst bring a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
10
countries conducted studies across a wide of therapeutic areas
7YEARS
As a clinical research contractor (CRO)
LEARN MORE ABOUT OUR THERAPEUTIC EXPERIENCE
At every stage of the drug development process, ReachCatalyst deploys the expertise you need to design, plan and execute your clinical trials with skill, precision and unwavering focus on quality.sers know a little more about you.
Oncology
ReachCatalyst is a leading oncology and hematology CRO committed to ensuring a smooth journey in the development of your compound.
Central Nervous System
We have deep knowledge of the nuances involved in successfully conducting CNS studies, from recruiting the right patients at the right time, to ensuring consistency in completing assessments, and ensuring all stakeholders involved are aligned
Infectious Disease
We understand the unique challenges associated with infectious disease clinical development and take your objectives to heart
Pain and Analgesia
We play a vital role in progressing clients’ compounds through the drug development process. Due to the suffering pain conditions can cause in patients’ lives, ReachCatalyst is committed to the advancement of pain clinical research. ReachCatalyst is your trusted partner wherever in the world you are.
Respiratory
Our expertise enables us to provide rapid feasibility and consulting services on a wide variety of respiratory protocol concepts and designs. As a result, our pharmaceutical and biotech clients can make decisions quickly and move their development programs forward at a rapid pace.
Cardiovascular disease (CVD)
We design efficient trials to meet the regulatory demand for direct assessment of risks and benefits using novel endpoints